Prevalence of hepatitis C virus infection in hemodialysis patients - PubMed (original) (raw)
Affiliations
- PMID: 18445917
Prevalence of hepatitis C virus infection in hemodialysis patients
O Taziki et al. Saudi J Kidney Dis Transpl. 2008 May.
Abstract
The prevalence of hepatitis C virus (HCV) infection in hemodialysis patients (HD) has decreased significantly during the past decade in most HD units. To evaluate the cause(s) of this reduction, we studied the HCV antibodies measurements in 1006 HD patients in the Province of Mazandaran, Iran, from January 2001 to December 2006. In December 2001, the prevalence of antibody to HCV was 18%, whereas by December 2006, it decreased to 12%. Causes implicated in the reduction of prevalence of HCV infection in HD patients include a low percentage of new anti-HCV+ patients, a decrease in the conversion rate in HD patients, and more strict infection control measures in the dialysis units.
Similar articles
- [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
Resić H, Sahović V, Mesić E, Leto E. Resić H, et al. Acta Med Croatica. 2003;57(1):39-42. Acta Med Croatica. 2003. PMID: 12876861 Croatian. - Hepatitis C virus infection among patients on hemodialysis: a report from a single center in Iran.
Nemati E, Alavian SM, Taheri S, Moradi M, Pourfarziani V, Einollahi B. Nemati E, et al. Saudi J Kidney Dis Transpl. 2009 Jan;20(1):147-53. Saudi J Kidney Dis Transpl. 2009. PMID: 19112238 - The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study.
Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, Barril G, Scheuermann E, Sonkodi S, Goubau P; HCV Collaborative Group. Jadoul M, et al. Nephrol Dial Transplant. 2004 Apr;19(4):904-9. doi: 10.1093/ndt/gfh012. Nephrol Dial Transplant. 2004. PMID: 15031348 - Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures.
Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Rahnavardi M, et al. Am J Nephrol. 2008;28(4):628-40. doi: 10.1159/000117573. Epub 2008 Feb 19. Am J Nephrol. 2008. PMID: 18285684 Review. - Hepatitis C infection in hemodialysis patients in Iran: a systematic review.
Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M. Alavian SM, et al. Hemodial Int. 2010 Jul;14(3):253-62. doi: 10.1111/j.1542-4758.2010.00437.x. Epub 2010 May 17. Hemodial Int. 2010. PMID: 20491973 Review.
Cited by
- Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.
Mohamoud YA, Miller FD, Abu-Raddad LJ. Mohamoud YA, et al. World J Gastroenterol. 2014 Sep 28;20(36):12734-52. doi: 10.3748/wjg.v20.i36.12734. World J Gastroenterol. 2014. PMID: 25278675 Free PMC article. Review. - Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.
Ramia S, Melhem NM, Kreidieh K. Ramia S, et al. Infection. 2012 Feb;40(1):1-10. doi: 10.1007/s15010-011-0236-z. Epub 2012 Jan 12. Infection. 2012. PMID: 22237470 Review. - The prevalence of hepatitis C virus in mashhad, iran: a population-based study.
Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, Rostami S, Meshkat Z. Shakeri MT, et al. Hepat Mon. 2013 Mar 12;13(3):e7723. doi: 10.5812/hepatmon.7723. Print 2013 Mar. Hepat Mon. 2013. PMID: 23745128 Free PMC article. - Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran.
Kargar Kheirabad A, Bahri F, Kargar M, Ghasemzadeh I. Kargar Kheirabad A, et al. Hepat Mon. 2016 Aug 13;16(10):e40375. doi: 10.5812/hepatmon.40375. eCollection 2016 Oct. Hepat Mon. 2016. PMID: 27882069 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous